Elligo Research Expands EU and U.K. Clinical Trial Support With WHYZE Health
Elligo Health Research Announces New CEO
Elligo & Avallano Launching Patient-First, AI-Powered Clinical Trials Ecosystem
Elligo Health Research Announces Expansion of Study Marketplace With Syneos Health
SCORR Marketing Wins 9 Awards for 9 Submissions at Healthcare Ad Awards
AUSTIN, Texas--(BUSINESS WIRE)--Elligo Health Research, the largest healthcare-enabling research organization, today announced that Dawn Sauro has been named as Elligo’s Chief Operating Officer (COO) to help further the company’s growth, efficiency, and mission of optimizing the intersection of healthcare and research through direct access to patients, new technology, and custom research practice management solutions.
AUSTIN, Texas--(BUSINESS WIRE)--Elligo Health Research®, the largest healthcare-enabling research organization, today announced Chief Scientific Officer Rebecca Kush, Ph.D., will bring her expertise in clinical research, standards, and interoperability to her role as recently elected Chair of the Vulcan Advisory Council. The Vulcan initiative was launched as part of the HL7 FHIR Accelerator Program to bring together stakeholders across the translational and clinical research community to streamline clinical research — leveraging standards to optimize the design, conduct, and reporting of clinical research studies.
Cerner Corporation has entered a partnership with Elligo Health Research and Freenome to boost access to clinical trials for cancer.
Electronic medical records miner Elligo already provides digital options to increase access to clinical research as care through its eSolutions Research Accelerator and ClinEdge Research Practice Management programs. Irish company WHYZE Health promises to deliver an intuitive, easy-to-use tool that gives patients more control over their course of care.
AUSTIN, Texas--(BUSINESS WIRE)--Elligo Health Research®, the ultimate healthcare-enabling research organization, today announced a new collaboration with WHYZE Health, a digital platform that strives to unify research, healthcare, and patient data — an integration that gives patients more control over their healthcare data and will break down barriers for participation in clinical trials. WHYZE Health CMO, Professor Frank Sullivan, and CEO of Elligo, John Potthoff, Ph.D., announce that their two companies will be jointly forming a European Medical Advisory Committee and inviting others in healthcare and clinical trials to join. The committee’s mission is to connect and empower more physicians, patients, and population health stakeholders to get access to the right clinical trials.